Page 10 - ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ARCEDI Biotech Announces Availability of EVITA TEST COMPLETE™ First Prenatal Genetic Blood Test to Identify and Isolate Fetal Cells in Maternal Blood Simple, Non-Invasive Blood Test Poses No Risk to Pregnant Woman and Fetus; Significantly Safer, More Comprehensive and More Inclusive Compared to Invasive Tissue Sampling Test Intended for All Pregnant Women, Not Just High-Risk Categories, at 10-14 Weeks of Pregnancy; Earlier Administration Potentially Leading to Higher Confidence and More Individualized Care Achievement Follows ARCEDI s Prior Non-Invasive Pregnancy Testing Innovations, Including Being the First Company to Identify Extravillous Trophoblasts as the Fetal Cell Types Circulating Within the Maternal Bloodstream News provided by

United kingdomPalle scheldeJohnny hindkjCompany media contactsAarhus university hospitalVirtus health onDenmark based aarhus university hospitalVirtus healthChief executive officerScientific directorLaboratory managerMedia contactsArcedi biotech apsஒன்றுபட்டது கிஂக்டம்நிறுவனம் மீடியா தொடர்புகள்ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை